Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Pravin U. Dugel, MD, Ocular's Executive Chairman, President and CEO, will provide an update regarding the enrollment status ...

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Want to improve your health and fitness in 2025? The good news is you don’t need a drastic lifestyle overhaul to make a difference. Small but impactful changes can significantly improve your wellbeing ...

Regeneron has bought Oxular, a UK-based specialist in retinal diseases, in a move that bolsters its already strong position ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...

snu.ac.kr Background/Aims To provide longer-term data on efficacy, safety, immunogenicity and pharmacokinetics (PK) of ranibizumab biosimilar SB11 compared with the reference ranibizumab (RBZ) in ...

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in patients ...

The ArMaDa clinical trial is currently being performed at 13 leading retinal surgery centers across the U.S. Dosing in the OCU410 ArMaDa clinical trial will be completed in early 2025 and the Company ...

Cashews are not only delicious but also packed with essential nutrients that support overall health. Here are 7 cashew ...

Up in simulcasting the other day, a member of the BDHC (Broken Down Horseplayers Club) was celebrating his birthday with ...